{{Promotional|date=January 2024}} {{Use mdy dates|date=September 2019}} '''Ravgen Inc.''' is a privately owned biotech company founded in 2000 by Chairman and C.E.O. Dr. Ravinder Dhallan.<ref>{{Cite conference|last1=Hanoon|first1=Alaa|last2=Rahan|first2=Nur Nadiah Mohd|last3=Hamid|first3=Nur Nadiah Abd|last4=Ismail|first4=Ahmad Izani Md|date=2018|title=Solving the nonlinear Camassa Holm equation using quartic trigonometric B-spline collocation method|conference=Mathematical Sciences as the Core of Intellectual Excellence (Sksm25)|series=AIP Conference Proceedings|publisher=Author(s)|volume=1974|issue=1|pages=020034|doi=10.1063/1.5041565|bibcode=2018AIPC.1974b0034H}}</ref> Ravgen Inc. performs research in the prenatal diagnostic field and has developed non-invasive prenatal diagnosis testing for Down Syndrome.<ref>{{cite web |last=Humphries |first=Courtney |date=February 2, 2007 |title=A Simpler Test for Detecting Down's Syndrome | MIT Technology Review |url=http://www.technologyreview.com/biomedicine/18139/ |accessdate=August 17, 2013 |publisher=Technologyreview.com}}</ref>
==Publications and research== Ravgen has published peer-reviewed articles on genetic research in publications such as the Journal of the American Medical Association in 2004,<ref>{{cite journal |last1=Dhallan |first1=Ravinder |last2=Au |first2=W. C. |last3=Mattagajasingh |first3=S. |last4=Emche |first4=S. |last5=Bayliss |first5=P. |last6=Damewood |first6=M. |last7=Cronin |first7=M. |last8=Chou |first8=V. |last9=Mohr |first9=M. |year=2004 |title=Methods to Increase the Percentage of Free Fetal DNA Recovered from the Maternal Circulation |url=http://jama.ama-assn.org/content/291/9/1114.abstract/ |journal=JAMA |publisher=The Journal of the American Medical Association |volume=291 |issue=9 |pages=1114–1119 |doi=10.1001/jama.291.9.1114 |pmid=14996781 |doi-access=free |archiveurl=https://web.archive.org/web/20120511014138/http://jama.ama-assn.org/content/291/9/1114.abstract |archivedate=May 11, 2012|url-access=subscription }}</ref> The Lancet in 2007,<ref>{{cite journal |last1=Dhallan |first1=Ravinder |last2=Guo |first2=Xin |last3=Emche |first3=Sarah |last4=Damewood |first4=Marian |last5=Bayliss |first5=Philip |last6=Cronin |first6=Michael |last7=Barry |first7=Julie |last8=Betz |first8=Jordan |last9=Franz |first9=Kara |last10=Gold |first10=Katie |last11=Vallecillo |first11=Brett |last12=Varney |first12=John |year=2007 |title=A noninvasive test for prenatal diagnosis based on fetal DNA present in maternal blood: a preliminary study |journal=The Lancet |volume=369 |issue=9560 |pages=474–481 |doi=10.1016/S0140-6736(07)60115-9 |pmid=17292767 |s2cid=43348652}}</ref> and the New England Journal of Medicine in 2012.<ref>{{cite journal |last1=Guo |first1=Xin |year=2012 |title=A Noninasive Test to Determine Paternity in Pregnancy |journal=The New England Journal of Medicine |volume=366 |issue=18 |pages=1743–1745 |doi=10.1056/NEJMc1113044 |pmid=22551147 |doi-access=free}}</ref> In addition, Ravgen has received some acclaim from its research on non-invasive prenatal DNA testing.<ref>{{cite news |date=February 2, 2007 |title=Health | Hope for safe prenatal gene test |url=https://news.bbc.co.uk/2/hi/health/6320273.stm |archive-url=https://web.archive.org/web/20120419105948/http://news.bbc.co.uk/2/hi/health/6320273.stm |archive-date=April 19, 2012 |access-date=August 17, 2013 |url-status=live |work=BBC News}}</ref>
==References== {{Reflist}}
==External links== * [http://www.ravgen.com Ravgen's official website] * [http://www.ravgen.com/index.php?mact=News,cntnt01,detail,0&cntnt01articleid=2&cntnt01returnid=52 JAMA (The Journal of the American Medical Association) "Methods to Increase the Percentage of Free Fetal DNA Recovered from the Maternal Circulation"] * [http://www.ravgen.com/index.php?mact=News,cntnt01,detail,0&cntnt01articleid=4&cntnt01returnid=52 The Lancet "A non-invasive test for prenatal diagnosis based on fetal DNA present in maternal blood: a preliminary study"]
Category:Biotechnology companies of the United States